&#xa0;
defaultIntroduction
defaultThe Society for General Microbiology (SGM) is a membership organisation for scientists who work in all areas of microbiology. It is the largest learned microbiological society in Europe with a worldwide membership based in universities, industry, hospitals, research institutes and schools. The SGM publishes key academic journals in microbiology and virology, organises international scientific conferences and provides an international forum for communication among microbiologists and supports their professional development. The Society promotes the understanding of microbiology to a diverse range of stakeholders, including policy-makers, students, teachers, journalists and the wider public, through a comprehensive framework of communication activities and resources. Further information about SGM is provided in Appendix 1.
default&#xa0;
defaultThe prevalence of antibiotic resistance should not surprise us. The problem is an inevitable consequence of human behaviour, evolutionary pressures and the ability of micro-organisms to rapidly change their genetic makeup. Despite this we believe that the scientific community – and broader society – is ingenious and determined enough to discover solutions that overcome the problems of antimicrobial resistance.
default&#xa0;
defaultOur emphasis in this consultation response is on the need for greater capacity in the basic research required to fight infection. Quite rightly basic research is proposed in the government’s 
defaultUK Five Year Antimicrobial Resistance Strategy,
default 
defaultas part of the overall solution to antibiotic resistance but details about how the research will be delivered were scarce. Basic research is, in our view, the only means of finding long-term solutions to the threat of antimicrobial resistance.
default&#xa0;
default1.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultHow has antimicrobial resistance developed in the past decade?
defaultIt is certain that micro-organisms can develop resistance to antimicrobial drugs; beyond this general statement, a more complex picture emerges in which some infections, notably, methicillin-resistant 
defaultStaphylococcus aureus
default (MRSA) and HIV show, respectively, declining and stable levels of resistance, while others, notably tuberculosis, register increases.
default For a third, and very large group of infections, we have little or no data on resistance patterns: surveillance in these infections is not carried out. Treatment failure may be occurring, but neither it, nor antimicrobial resistance, is being 
defaultsystematically reported.
default The most serious disease threats are from chronic infections including multidrug resistant tuberculosis, Gram-negative infections and hospital-acquired infections.
default&#xa0;
default2.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultWhat are the gaps in our knowledge about antimicrobial resistance?
default2.1.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultDiagnosis of antimicrobial resistance and routine surveillance of resistance rates
default2.2.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultExpanding the working life of existing antimicrobial treatments and developing new ones
default&#xa0;
default3.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultIs there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not, how could this be rectified?
default&#xa0;
default4.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultWhat measures (including behavioural change) have been most effective in controlling the spread of resistant pathogens, and could such measures be used to control other pathogens?
defaultNo comment.
default&#xa0;
default5.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultWhat global coordination and action is required to fight antimicrobial resistance and is the UK contributing enough towards cross-border initiatives?
defaultNo comment.
default&#xa0;
default6.
default&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; 
defaultWhat are the strengths and weaknesses of the Government’s 2013-2018 strategy for tackling antimicrobial resistance? What changes might be made to further strengthen the Government’s action plan?
default&#xa0;
defaultSociety for General Microbiology – Chair of the Policy Committee:default&#xa0;
defaultSociety for General Microbiology – Policy Committee:default&#xa0;
defaultThe Policy Committee additionally sought information from Dr Mike Dawson (Novacta Biosystems Ltd), Professor David Denning (University Hospital of South Manchester), Professor David Dunn (MRC Clinical Trials Unit), Dr Malcolm Rhodes (University of Manchester), Professor Jodi Lindsay (St George’s University of London), and Professor David Livermore (Lead, Antibiotic Resistance, Public Health England) in preparing this response.
default&#xa0;
defaultNovember 2013
default&#xa0;
default&#xa0;
defaultA world in which the science of microbiology provides maximum benefit to society.
default&#xa0;
defaultTo promote high-quality microbiological science, both nationally and internationally, to a diverse range of stakeholders.
default&#xa0;
defaultThe potential socio-economic benefits arising from microbiology are substantial. They include:
default&#xa0;
defaultTo achieve its Vision and Mission, the Society will work towards the strategic priorities below.
default&#xa0;
defaultThe Society is a Charity registered in England and Wales (No. 264017) and in Scotland (No.
defaultSC039250) and a Company Limited by Guarantee, registered in England and Wales (No.
default1039582).
default&#xa0;
default&#xa0;
default&#xa0;
default 
defaultDepar
defaulttment of Health/
defaultDepartment for the Environment, Food and Rural Affairs
default,
default 
defaultUK Five Year Antimicrobial Resistance Strategy 2013 to 2018
default; 
defaulthttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf
default 
default 
defaultAlan P. Johnson, John Davies, Rebecca Guy, Julia Abernethy, Elizabeth Sheridan, Andrew Pearson and Georgia Duckworth (2012).default 
defaultMandatory surveillance of methicillin-resistant 
defaultStaphylococcus aureus
default (MRSA) bacteraemia
default in England: the first 10 years. 
defaultJournal of Antimicrobial Chemotherapy,
default doi: 10.1093/jac/dkr561 (Figure 1); 
defaulthttp://jac.oxfordjournals.org/content/67/4/802.full
default. 
defaultUK Collaborative Group on HIV Drug Resistance (2012).default 
defaultTime trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study. 
defaultBritish Medical Journal,
default 
defaultdoi: 10.1136/bmj.e5253
default, 
defaulthttp://www.bmj.com/content/345/bmj.e5253
default. Public Health England, July 2013, ‘
defaultNumber and proportion of tuberculosis cases with first line drug
default resistance, UK, 2000-2012’; 
defaulthttp://www.hpa.org.uk/webc/HPAwebFile/HPAweb_C/1317139697461
default.
default To the best of our knowledge, no comprehensive account of UK resistance rates has been published since 2007; 
defaultwww.hpa.org.uk/Publications/InfectiousDiseases/AntimicrobialAndHealthcareAssociatedInfections/0712Antimicrobialresistance/
default.
default 
defaulthttp://grants.nih.gov/grants/guide/rfa-files/RFA-AI-12-020.html
default 
defaulthttp://blogs.nature.com/news/2012/05/europe-targets-superbugs-with-public-private-effort.html
default 
default 
defaultSociety for General Microbiology Consultation Response
default:
default Research and Development funding for science and technology in the UK
default, 28 August 2013. Please contact SGM for a list of firms.
default 
defaultMichael G. Head, Joseph R. Fitchett, Mary K. Cooke, Fatima B. Wurie, Rifat Atun, Andrew C. Hayward, Alison Holmes, Alan P. Johnson, and Neil Woodford (2013). defaultSystematic analysis of funding awarded for antimicrobial resistance research to institutions in the UK, 1997-2010. 
defaultJournal of Antimicrobial Chemotherapy,
default 
defaultdoi: 10.1093/jac/dkt349
default, 
defaulthttp://jac.oxfordjournals.org/content/early/2013/09/13/jac.dkt349.full
default. 
defaultA word cloud available online shows this funding 
defaultshortfall
default graphically
default - 
defaulthttp://www.researchinvestments.org/
default. These data run until 2010 only; later data are not yet available.
default SGM can supply a full list of the initiatives we are aware about – please contact us. SGM currently collaborates with other learned societies on antimicrobial resistance; these include the Biochemical Society, British Society for Antimicrobial Chemotherapy, Royal Society of Chemistry, Society for Applied Microbiology and Society of Biology.
default 
defaultAcademy of Sciences and Humanities in Hamburg/German National Academy of Sciences Leopoldina (2013default). 
defaultAntibiotics Research: Problems 
defaultand Perspectives
default, p. 10; 
defaulthttp://www.leopoldina.org/uploads/tx_leopublication/2013_06_17_Antibiotics_Research.pdf
default. 
default 
defaultAntibiotic Action (2013). defaultLessons to be 
defaultlearnt from P
defaultharma
default about D
defaultiscovery and 
defaultD
defaultevelopment 
defaultof N
defaultew 
defaultA
defaultntibacterial 
defaultD
defaultrugs,
default p. 3; 
defaulthttp://antibiotic-action.com/wp-content/uploads/2013/08/Learning-Lessons-report.pdf
default. 
default 
defaultDepar
defaulttment of Health/
defaultDepartment for the Environment, Food and Rural Affairs
default,
default 
defaultUK Five Year Antimicrobial Resistance Strategy 2013 to 2018
default; 
defaulthttps://www.gov.uk/government/uploads/system/uploads/attachment_data/file/244058/20130902_UK_5_year_AMR_strategy.pdf
default 
default For a programmatic statement of SGM’s current policy approach, please see: 
defaultSociety for General Microbiology 
defaultPolicy Note: Antimicrobial Resistance Policy, 7 June 2013; 
defaulthttp://www.sgm.ac.uk/en/policy/consultation-responses.cfm
default. 
default